. 2023 Jan 20;54(1):186–191. [Article in Chinese] doi: 10.12182/20230160111

表 5. Comparison of Hp-positive and Hp-negative subjects in each group, using cut-off value to screen for positive population (case [%]).

各组Hp阳性、Hp阴性者应用cut-off值筛选阳性人群比较〔例数（%）〕

Group	Hp	n	PGⅠ/PGⅡ		CEA/(ng/mL)		CA199/(U/mL)		CA724/(U/mL)
Group	Hp	n	>2.32	≤2.32	>66.99	≤66.99	>110.35	≤110.35	>44.20	≤44.20
^a P<0.05, vs. Hp-negative patients in gastric cancer group.
Healthy	+	26	24 (92.31)	2 (7.69)	0 (0.00)	26 (100.00)	0 (0.00)	26 (100.00)	0 (0.00)	26 (100.00)
	－	78	77 (98.72)	1 (1.28)	0 (0.00)	78 (100.00)	0 (0.00)	78 (100.00)	0 (0.00)	78 (100.00)
Benign	+	90	83 (92.22)	7 (7.78)	0 (0.00)	90 (100.00)	0 (0.00)	90 (100.00)	0 (0.00)	90 (100.00)
	－	25	25 (100.00)	0 (0.00)	0 (0.00)	25 (100.00)	0 (0.00)	25 (100.00)	0 (0.00)	25 (100.00)
Low grade	+	86	71 (85.54)	15 (18.07)	0 (0.00)	86 (100.00)	0 (0.00)	86 (100.00)	0 (0.00)	86 (100.00)
	－	26	25 (96.15)	1 (3.85)	0 (0.00)	26 (100.00)	0 (0.00)	26 (100.00)	0 (0.00)	26 (100.00)
High grade	+	83	72 (86.75)	11 (13.25)	1 (1.20)	82 (98.80)	2 (2.41)	81 (97.59)	1 (1.20)	82 (98.80)
	－	26	24 (92.31)	2 (7.69)	0 (0.00)	26 (100.00)	0 (0.00)	26 (100.00)	0 (0.00)	26 (100.00)
Gastric cancer	+	81	16 (19.75)^a	65 (80.25)^a	63 (77.78)^a	18 (22.22)^a	66 (81.48)^a	15 (18.52)^a	64 (79.01)^a	17 (20.99)^a
	－	28	21 (75.00)	7 (25.00)	7 (25.00)	21 (75.00)	8 (28.57)	20 (71.43)	6 (21.43)	22 (78.57)